Physician profile
Robert A Jaskot
NPI 1659372308
$4,242.31
in general payments reported to CMS, 2019-2025
32 companies · $855 in 2025
The $855 reported for 2025 was more than what 89% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $413 · 2020: $201 · 2021: $375 · 2022: $854 · 2023: $898 · 2024: $647 · 2025: $855.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,235 · Education: $165.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,234.73 |
| Education | $164.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $652.59 | 2019-2025 | Veozah |
| Minerva Surgical, INC | $643.89 | 2019-2024 | |
| Abbvie INC. | $550.88 | 2019-2024 | |
| Organon LLC | $249.20 | 2021-2025 | Nexplanon |
| Pfizer INC. | $218.07 | 2019-2024 | |
| Sumitomo Pharma America, INC. | $198.31 | 2023-2025 | Myfembree |
| Hologic Sales and Service, LLC | $196.21 | 2019-2025 | Aptima, Novasure, Acessa Provu System |
| Amgen INC. | $159.86 | 2019-2025 | Evenity, Prolia, Prolia |
| Exeltis, USA INC. | $154.68 | 2019-2025 | Slynd |
| Exact Sciences Corporation | $151.40 | 2024-2025 | Cologuard Collection Kit |
| Novo Nordisk INC | $111.39 | 2024 | Wegovy |
| Shield Therapeutics INC | $110.77 | 2023-2025 | Accrufer |
| Biogen, INC. | $81.75 | 2025 | Zurzuvae |
| Aspira Women'S Health INC | $81.12 | 2022 | |
| Therapeuticsmd, INC. | $80.29 | 2019-2022 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $70.65 | 2020 | |
| Channel Medsystems, INC. | $70.00 | 2023 | |
| Merck Sharp & Dohme LLC | $65.98 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $55.17 | 2020-2025 | |
| Mayne Pharma Commercial LLC | $54.98 | 2023-2025 | |
| Meditrina | $49.10 | 2019-2024 | |
| Millicent US INC | $43.43 | 2024-2025 | Femlyv, Intrarosa, Femring |
| Intuitive Surgical, INC. | $35.00 | 2023 | |
| Becton, Dickinson and Company | $26.86 | 2019 | |
| Amag Pharmaceuticals, INC. | $24.33 | 2019-2020 | |
| Optumhealth Care Solutions, LLC | $18.59 | 2025 | Vivify Health Care Team Portal 001, Eitan Medical |
| Convatec INC. | $17.77 | 2025 | |
| Boston Scientific Corporation | $17.53 | 2023 | |
| Agile Therapeutics, INC. | $14.50 | 2022 | |
| Medicem INC. | $14.08 | 2020 | |
| Janssen Pharmaceuticals, INC | $12.93 | 2022 | |
| Bard Access Systems, INC. | $11.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Jaskot listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.